Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Andre Abdo"'
Autor:
Andreas Hochhaus, Delphine Réa, Carla Boquimpani, Yosuke Minami, Jorge E. Cortes, Timothy P. Hughes, Jane F. Apperley, Elza Lomaia, Sergey Voloshin, Anna Turkina, Dong-Wook Kim, Andre Abdo, Laura Maria Fogliatto, Philipp le Coutre, Koji Sasaki, Dennis Dong Hwan Kim, Susanne Saussele, Mario Annunziata, Naeem Chaudhri, Lynette Chee, Valentin García-Gutiérrez, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Michael J. Mauro
Publikováno v:
Leukemia. 37:617-626
Asciminib, the first BCR::ABL1 inhibitor that Specifically Targets the ABL Myristoyl Pocket (STAMP), is approved worldwide for the treatment of adults with Philadelphia chromosome–positive chronic myeloid leukemia in chronic phase (CML-CP) treated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::925b1dff371f56d5e87a1cf9f4fe14f0
https://doi.org/10.1038/s41375-023-01829-9
https://doi.org/10.1038/s41375-023-01829-9
Autor:
Andre Abdo, Leandro Menezes Alves da Costa, Andrei Skromov de Albuquerque, Rafael Amorim Belo Nunes
Publikováno v:
Hematology, Transfusion and Cell Therapy. 45:127-130
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51362ec4ca91f12b8c817ccda1e94f12
https://doi.org/10.1016/j.htct.2021.06.016
https://doi.org/10.1016/j.htct.2021.06.016
Autor:
Philipp le Coutre, Véronique Bédoucha, Delphine Rea, Dennis Dong Hwan Kim, Elza Lomaia, Michael J. Mauro, Andre Abdo, Lynette Chee, Sergey Voloshin, Dong-Wook Kim, Laura Fogliatto, Paola Aimone, Yosuke Minami, Alex Allepuz, Mario Annunziata, Jane F. Apperley, Susanne Saussele, Jorge E. Cortes, Andreas Hochhaus, Naeem Chaudhri, Carla Boquimpani, Koji Sasaki, Sara Quenet, Timothy P. Hughes, Anna G. Turkina, Valentín García-Gutiérrez
Publikováno v:
Blood
Patients with chronic myeloid leukemia in chronic phase (CML-CP) resistant/intolerant to ≥2 tyrosine kinase inhibitors (TKIs) are at high risk of experiencing poor outcomes because of disease biology and inadequate efficacy and/or safety of current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ea953c680d4e6fe9a23516537c5aa9
https://doi.org/10.1182/blood.2020009984
https://doi.org/10.1182/blood.2020009984
Autor:
Laura Fogliatto, Andre Abdo, Monika Conchon, Carla Maria Boquimpani de Moura, Carolina Maria Pinto Domingues Carvalho Silva, Vaneuza Araujo Moreira Funke, Fernanda S Seguro, José Francisco Kerr Saraiva, Ariane Vieira Scarlatelli Macedo, Marilia Harumi Higushi dos Santos
Publikováno v:
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy, Volume: 43, Issue: 2, Pages: 191-200, Published: 07 JUL 2021
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 2, Pp 191-200 (2021)
Hematology, Transfusion and Cell Therapy, Volume: 43, Issue: 2, Pages: 191-200, Published: 07 JUL 2021
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 2, Pp 191-200 (2021)
This manuscript summarizes the results of the consensus meeting composed of hematologists and cardiologists to establish recommendations for the prevention and follow-up of cardiovascular (CV) risk in patients with chronic myeloid leukemia (CML) trea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2b335354366410c715101f09f6cb478
https://doi.org/10.1016/j.htct.2020.04.009
https://doi.org/10.1016/j.htct.2020.04.009
Autor:
Sagar Lonial, Vania Hungria, Andrew Spencer, Pierre Maison-Blanche, Roman Hájek, Lutz Jacobasch, Chantana Polprasert, Joan Bladé, Paul G. Richardson, Ewa Lech-Marańda, Philippe Moreau, Meletios A. Dimopoulos, Árpád Illés, Fredrik Schjesvold, Andre Abdo, Jesús F. San-Miguel, Ajai Chari, S. Vincent Rajkumar, Anna Sureda, Ivan Spicka, Iara Z Gonçalves, Meral Beksac, Jacob P. Laubach, Tatiana Shelekhova, Mário Mariz, Tomasz Wróbel
Publikováno v:
The Lancet Oncology. 22:142-154
Summary Background Improved therapeutic options are needed for patients with relapsed or relapsed and refractory multiple myeloma. Subcutaneous bortezomib has replaced intravenous bortezomib as it is associated with a more favourable toxicity profile
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::416e02e0de68e82b49b94964486dc3a5
https://doi.org/10.1016/s1470-2045(20)30680-x
https://doi.org/10.1016/s1470-2045(20)30680-x
Autor:
Denise Pires Martins, Israel Bendit, Andre Abdo, Mayde Seadi Torriani, Luciana Britto de Abreu Lima, Carla Boquimpani
Publikováno v:
Hematology, Transfusion and Cell Therapy
Hematology, Transfusion and Cell Therapy, Volume: 43, Issue: 1, Pages: 50-57, Published: 26 MAR 2021
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 1, Pp 50-57 (2021)
Hematology, Transfusion and Cell Therapy, Volume: 43, Issue: 1, Pages: 50-57, Published: 26 MAR 2021
Hematology, Transfusion and Cell Therapy, Vol 43, Iss 1, Pp 50-57 (2021)
Introduction Chronic Myeloid Leukemia (CML) is a myeloproliferative disease that affects mainly adults between 50 and 55 years. In Brazil, information from the Sistema Unico de Saude (SUS) Outpatient Information System indicates that 12,531 patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9841292095499bd7778c7a37773ac5ee
https://doi.org/10.1016/j.htct.2020.02.002
https://doi.org/10.1016/j.htct.2020.02.002
Autor:
Bonnie Ky, Cristina Salvadori Bittar, Sheila Aparecida Coelho Siqueira, Ludhmila Abrahão Hajjar, Fernanda A. de S. Costa, Andre Abdo, Juliana Pereira, Vanderson Rocha, Stephanie Itala Rizk, Isabela Bispo Santos da Silva Costa
Publikováno v:
JACC: CardioOncology
JACC. CardioOncology, Vol 2, Iss 2, Pp 324-328 (2020)
JACC. CardioOncology, Vol 2, Iss 2, Pp 324-328 (2020)
Erdheim-Chester disease (ECD) is classified as an inflammatory myeloid neoplasia that has an unknown origin and low incidence (∼600 cases described in the literature) ([1][1],[2][2]). ECD is multisystemic, affecting the bones, skin, ocular tissue,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc5f5145d92e74d09126bb268fc8ccd1
http://europepmc.org/articles/PMC8352341
http://europepmc.org/articles/PMC8352341
Autor:
Xin Xin Cao, Benjamin H. Durham, Paul C. Hendrie, Aaron M. Goodman, Jennifer Picarsic, Eric D. Jacobsen, Juvianee Estrada-Veras, Andre Abdo, Michael Girschikofsky, Matthew Collin, Kenneth L. McClain, Mineo Kurokawa, Ronald S. Go, Augusto Vaglio, Mark L. Heaney, Kazuhiro Toyama, Lorenzo Dagna, Julien Haroche, Oshrat Hershkovitz-Rokah, Eli L. Diamond, Ofer Shpilberg, Roei D Mazor, Filip Janku, Fleur Cohen-Aubart, Gaurav Goyal
Publikováno v:
Blood. 135:1929-1945
Erdheim-Chester disease (ECD) is a rare histiocytosis that was recently recognized as a neoplastic disorder owing to the discovery of recurrent activating MAPK (RAS-RAF-MEK-ERK) pathway mutations. Typical findings of ECD include central diabetes insi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::643c84dd0009f0b3486eb4df9411236d
https://doi.org/10.1182/blood.2019003507
https://doi.org/10.1182/blood.2019003507
Autor:
Giovanna Iantevi Ghelfond, Israel Bendit, Fernanda Maria Santos, Andre Abdo, Thales Dalessandro, Fernanda S Seguro, Felipe Vieira Rodrigues Maciel, Vanderson Rocha, Lucas Bassolli
Publikováno v:
American Journal of Hematology. 97
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cf4ae2cbffed2ff0558f98e88c87a1c
https://doi.org/10.1002/ajh.26424
https://doi.org/10.1002/ajh.26424
Autor:
Delphine Réa, Andreas Hochhaus, Michael J. Mauro, Yosuke Minami, Elza Lomaia, Sergey Voloshin, Anna Turkina, Dong-Wook Kim, Jane F. Apperley, Jorge E. Cortes, Andre Abdo, Laura Marie Fogliatto, Dennis Dong Hwan Kim, Philipp le Coutre, Susanne Saussele, Mario Annunziata, Timothy P. Hughes, Naeem Chaudhri, Lynette Chee, Valentin García-Gutiérrez, Koji Sasaki, Shruti Kapoor, Alex Allepuz, Sara Quenet, Véronique Bédoucha, Carla Boquimpani
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S145
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fb133b2aeaf6d7ce8df88e584eed0da
https://doi.org/10.1016/s2152-2650(22)00881-3
https://doi.org/10.1016/s2152-2650(22)00881-3